ACLARIS THERAPEUTICS INC's ticker is ACRS and the CUSIP is 00461U105. A total of 83 filers reported holding ACLARIS THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.08 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $1,570,000 | -0.2% | 87,005 | -4.9% | 0.00% | 0.0% |
| Q2 2021 | $1,573,000 | -17.3% | 91,480 | +39.9% | 0.00% | 0.0% |
| Q1 2021 | $1,902,000 | +116.1% | 65,382 | -53.0% | 0.00% | 0.0% |
| Q4 2020 | $880,000 | +8700.0% | 139,229 | +2435.6% | 0.00% | – |
| Q4 2019 | $10,000 | +233.3% | 5,491 | +74.0% | 0.00% | – |
| Q3 2019 | $3,000 | -57.1% | 3,156 | +2.4% | 0.00% | – |
| Q2 2019 | $7,000 | +75.0% | 3,082 | +308.8% | 0.00% | – |
| Q1 2019 | $4,000 | -42.9% | 754 | -21.5% | 0.00% | – |
| Q4 2018 | $7,000 | 0.0% | 961 | +100.2% | 0.00% | – |
| Q3 2018 | $7,000 | -95.6% | 480 | -94.0% | 0.00% | – |
| Q2 2018 | $159,000 | +16.1% | 7,944 | +2.0% | 0.00% | – |
| Q1 2018 | $137,000 | +1422.2% | 7,792 | +1966.8% | 0.00% | – |
| Q4 2017 | $9,000 | -10.0% | 377 | 0.0% | 0.00% | – |
| Q3 2017 | $10,000 | -94.8% | 377 | -94.7% | 0.00% | – |
| Q2 2017 | $194,000 | +1663.6% | 7,137 | +1793.1% | 0.00% | – |
| Q1 2017 | $11,000 | 0.0% | 377 | 0.0% | 0.00% | – |
| Q4 2016 | $11,000 | – | 377 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management V, LLC | 1,258,243 | $8,618,965 | 13.75% |
| Foresite Capital Management IV, LLC | 2,808,034 | $19,235,033 | 10.68% |
| Bain Capital Life Sciences Investors, LLC | 3,400,000 | $23,290,000 | 2.60% |
| GREAT POINT PARTNERS LLC | 1,691,768 | $11,588,611 | 2.11% |
| Samsara BioCapital, LLC | 696,171 | $4,768,771 | 1.46% |
| Altium Capital Management LP | 403,000 | $2,760,550 | 1.44% |
| BVF INC/IL | 7,064,736 | $48,393,442 | 1.30% |
| Aisling Capital Management LP | 434,455 | $2,976,017 | 1.23% |
| GREAT POINT PARTNERS LLC | 700,000 | $4,795,000 | 0.87% |
| VR Adviser, LLC | 1,040,754 | $7,129,165 | 0.75% |